| 英文名称 | | 中文名称 | | CAS |
---|---|---|
E 1210 (pharMaceutical) | E 1210 (pharMaceutical) | 936339-60-5 |
ONO-8130 | ONO-8130 | 459841-96-4 |
3-nitro-N-(4-phenoxyphenyl)-benzamide | 化合物ICA-105574 | 316146-57-3 |
Sovilnesib | Sovilnesib | 2410796-79-9 |
2-Pyridinecarboxamide, 6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]-N-methyl- | AZD-9574 | 2756333-39-6 |
GTQTUABHRCWVLL-UHFFFAOYSA-N | 1383450-81-4 | 1383450-81-4 |
Epiblastin A | Epiblastin A | 16470-02-3 |
(6aR,9R,10aR)-9-N-[3-(dimethylamino)propyl]-4-N-ethyl-9-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4,9-dicarboxamide | (6aR,9R,10aR)-9-N-[3-(dimethylamino)propyl]-4-N-ethyl-9-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4,9-dicarboxamide | 126554-50-5 |
PD089828 | PD089828 | 179343-17-0 |
BMS-1001 | BMS-1001 | 2113650-04-5 |
3-(1,3-benzothiazol-5-yl)-7-(1,3-dimethyl-1H-pyrazol-5-yl)thieno[3,2-c]pyridin-4-amine | GSK-843 | 1601496-05-2 |
FIT-039 | FIT-039 | 1113044-49-7 |
NBI-31772 hydrate | NBI-31772 hydrate | 374620-70-9 |
MN58b | 化合物MN58B | 203192-01-2 |
ACBI1 | ACBI1 | 2375564-55-7 |
KPT 251, >=98% | SCHEMBL11318201; AOB6639; | 1388841-50-6 |
JPQNPPCKEMAVMD-UHFFFAOYSA-N | 2-溴-4-氟-5-氨基苯乙酸乙酯 | 1442471-26-2 |
Leucettine L41 | 化合物 T24402 | 1112978-84-3 |
AS-2444697 | AS-2444697 | 1287665-60-4 |
CAY10526 | CAY10526 | 938069-71-7 |